ARCHIVES

In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974

Cancer, AIDS Drug Screening Contracts Ok’d For Recompetition

February 28, 1992

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985

Lung Cancer Screening Trial Opens

September 20, 2002

Bill Introduced To Curb NIH Use Of Title 42 Salaries

August 10, 2012